Notice of the State Drug Administration on Publicizing the List of the Second Batch of Key Laboratories

In accordance with the relevant provisions of the "Administrative Measures for Key Laboratories of the State Drug Administration" (GuoYin Jian Ke Wai [2019] No.
56), upon voluntary application by the supporting unit, preliminary verification recommendation, formal review, defense review, and review by the local provincial drug regulatory authority For on-site verification and comprehensive review and other procedures, the State Drug Administration has drawn up the second batch of key laboratories list, which is now publicly announced, and the publicity time is from January 22 to January 28, 2021
.

During the publicity period, if there is any objection to the publicity object, it can be reported to the State Drug Administration
.
All materials reflecting the situation in the name of the unit must be stamped with the official seal of the unit, and materials reflecting the situation in the name of the individual must have their real names and contact information

Contact: Tao Yamin

Contact number: 010-88331105

Email: kbskjc@nmpa.

Mailing address: Department of Science, Technology and International Cooperation, National Medical Products Administration, Building 1, Beiluyuan, Zhanzhan Road, Xicheng District, Beijing

Post Code: 100037

Attachment: Publicity of the second batch of key laboratories approved by the State Food and Drug Administration

Science, Technology and International Cooperation Division

January 22, 2021

Attachment: The second batch of key laboratories of the State Food and Drug Administration has passed the review list publicity.